39.52
-2.34 (-5.59%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Bearish | |
| Stock | Medline Inc. | - | - |
AIStockmoo Score
| Analyst Consensus | 4.0 |
| Insider Activity | NA |
| Price Volatility | 1.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | 1.25 |
|
Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Mid Growth |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 60.00 (Citigroup, 51.82%) | Buy |
| 60.00 (Tigress Financial, 51.82%) | Buy | |
| Median | 54.50 (37.91%) | |
| Low | 47.00 (Wells Fargo, 18.93%) | Hold |
| Average | 54.60 (38.16%) | |
| Total | 9 Buy, 1 Hold | |
| Avg. Price @ Call | 46.10 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Citigroup | 11 Mar 2026 | 60.00 (51.82%) | Buy | 42.39 |
| 26 Feb 2026 | 60.00 (51.82%) | Buy | 48.89 | |
| JP Morgan | 10 Mar 2026 | 53.00 (34.11%) | Buy | 42.88 |
| BTIG | 09 Mar 2026 | 55.00 (39.17%) | Buy | 43.41 |
| Tigress Financial | 09 Mar 2026 | 60.00 (51.82%) | Buy | 43.41 |
| Morgan Stanley | 02 Mar 2026 | 52.00 (31.58%) | Buy | 45.85 |
| Wells Fargo | 27 Feb 2026 | 47.00 (18.93%) | Hold | 47.51 |
| BMO Capital | 26 Feb 2026 | 54.00 (36.64%) | Buy | 48.89 |
| Evercore ISI Group | 26 Feb 2026 | 55.00 (39.17%) | Buy | 48.89 |
| RBC Capital | 26 Feb 2026 | 53.00 (34.11%) | Buy | 48.89 |
| UBS | 26 Feb 2026 | 57.00 (44.23%) | Buy | 48.89 |
| Show more | ||||
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |